| abstract |
The present invention provides a binding molecule comprising two polypeptide chains, wherein the peptide chains allow only heterodimerization, thereby preventing homodimerization, a binding molecule comprising a modified EHD2 domain, said binding molecule comprising nucleic acids encoding said binding molecules, and to the use of said binding molecules or nucleic acids encoding said binding molecules in therapy. |